Search results for "Diuretics"

showing 10 items of 85 documents

Performance of micellar mobile phases in reversed-phase chromatography for the analysis of pharmaceuticals containing beta-blockers and other antihyp…

1996

A rapid and simple reversed-phase micellar liquid chromatographic procedure for the simultaneous determination of the beta-blockers atenolol, metoprolol and oxprenolol, the diuretics amiloride, bendroflumethiazide, chlorthalidone and hydrochlorothiazide and the vasodilator hydralazine in pharmaceuticals, is proposed. An interpretive optimization procedure, which uses the chromatographic data for only five mobile phases, was applied to select a suitable micellar mobile phase. A comparative study was also made of the performance of micellar and aqueous-organic mobile phases in the analysis of pharmaceuticals that combine beta-blockers and diuretics. The determination of all the drugs could be…

ChromatographyAdrenergic beta-AntagonistsReversed-phase chromatographyAtenololHydralazineBiochemistryHigh-performance liquid chromatographyDosage formAnalytical Chemistrychemistry.chemical_compoundHydrochlorothiazidechemistryOxprenololElectrochemistrymedicineSolventsEnvironmental ChemistryBendroflumethiazideSodium dodecyl sulfateDiureticsSpectroscopyAntihypertensive AgentsChromatography High Pressure LiquidMicellesmedicine.drugThe Analyst
researchProduct

Furosemide assay in pharmaceuticals by Micellar liquid chromatography: study of the stability of the drug.

2000

A simplified high-performance liquid chromatographic procedure is described for the determination of furosemide (4-chloro-N-furfuryl-5-sulphamoylanthranillic acid), which makes use of UV detection, a C18, reversed-phase column, and micellar mobile phases of sodium dodecyl sulphate (SDS) and 1-propanol at pH 3 buffered with phosphate system. The most adequate experimental conditions to handle furosemide solutions in the analytical laboratory are studied. The mixture of furosemide and its degradation products which are formed upon light exposition was resolved with a mobile phase of 0.04 M SDS-2% propanol. Separation of furosemide from its common impurities and the hydrolytic product, 4-chlor…

Clinical BiochemistryPharmaceutical ScienceDosage formMicellar electrokinetic chromatographyAnalytical ChemistryPropanolchemistry.chemical_compoundDrug StabilityFurosemideDrug DiscoverymedicineSodium dodecyl sulfateDiureticsSpectroscopyChromatography High Pressure LiquidMicellesChromatographyPhotolysisElutionHydrolysisFurosemideSodium Dodecyl SulfateHydrogen-Ion ConcentrationSolutionschemistryMicellar liquid chromatographyCalibrationIndicators and ReagentsSpectrophotometry UltravioletQuantitative analysis (chemistry)medicine.drugTabletsJournal of pharmaceutical and biomedical analysis
researchProduct

Determination of furosemide in urine samples by direct injection in a micellar liquid chromatographic system.

2002

A sensitive, selective and efficient micellar liquid chromatographic (MLC) procedure was developed for the determination of furosemide (4-chloro-N-furfuryl-5-sulfamoylanthranilic acid) in urine samples by direct injection and UV detection. The procedure makes use of a C18 reversed-phase column and a micellar mobile phase of 0.05 mol l(-1) sodium dodecyl sulfate-6% v/v propanol and phosphate buffer at pH 3 to resolve furosemide from its photochemical degradation products. The importance of protecting the standards and urine samples to be analysed from light in the assay of furosemide, avoiding its degradation, was verified. The limit of quantification was 0.15 microg ml(-1) and the relative …

Detection limitChromatographyMetabolitemedicine.medical_treatmentSodiumchemistry.chemical_elementFurosemideReversed-phase chromatographyUrineBiochemistryAnalytical Chemistrychemistry.chemical_compoundchemistryFurosemideElectrochemistrymedicineEnvironmental ChemistryHumansDiureticDiureticsQuantitative analysis (chemistry)SpectroscopyChromatography High Pressure Liquidmedicine.drugChromatography Micellar Electrokinetic CapillaryThe Analyst
researchProduct

Column-switching techniques for screening of diuretics and probenecid in urine samples

1994

A method based on high-performance liquid chromatography using column-switching is described for the screening of diuretics and probenecid in urine samples. The system uses a 20- x 2.1-mm i.d. precolumn, packed with a Hypersil ODS-C18, 30-microns stationary phase, for the on-line sample cleanup and enrichment. Untreated urine samples are directly injected, and the precolumn is flushed for 1 min with water to eliminate polar matrix components. The retained analytes are then back-flushed by means of a six-port switching valve onto a Hypersil ODS-C18 analytical column (5 microns, 250- x 4-mm i.d.), where they are separated using an acetonitrile/phosphate buffer (pH = 3) gradient elution. Under…

Doping in SportsAnalyteChromatographyProbenecidChemistrymedicine.medical_treatmentUrineAnalytical ChemistryProbenecidchemistry.chemical_compoundmedicineHumansGradient elutionColumn switchingDiureticDiureticsAcetonitrileQuantitative analysis (chemistry)Chromatography High Pressure Liquidmedicine.drugAnalytical Chemistry
researchProduct

Approaches to model the retention and peak profile in linear gradient reversed-phase liquid chromatography.

2012

Abstract The optimisation of the experimental conditions in gradient reversed-phase liquid chromatography requires reliable algorithms for the description of the retention and peak profile. As in isocratic elution, the linear relationship between the logarithm of the retention factor and the solvent contents is only acceptable in relatively small concentration ranges of modifier. However, more complex models may not allow an analytical integration of the general equation for gradient elution. Alternative approaches for modelling the retention in linear gradient elution are here proposed. Those based on the quadratic logarithmic model and a model proposed for normal liquid chromatography yie…

FlavonoidsChromatography Reverse-PhaseIsocratic elutionChromatographyAcetonitrilesLogarithmChemistryElutionOrganic ChemistryAnalytical chemistryWaterGeneral MedicineReversed-phase chromatographyBiochemistryAnalytical ChemistryLinear gradientSolventModels ChemicalGradient elutionDiureticsRetention timeAlgorithmsJournal of chromatography. A
researchProduct

Diuretic Treatment in Heart Failure.

2018

Heart Failuremedicine.medical_specialtySettore MED/09 - Medicina Internabusiness.industryDiuretic heart failureTreatment outcomeMEDLINEGeneral Medicine030204 cardiovascular system & hematologymedicine.diseaseDiuretic treatment03 medical and health sciences0302 clinical medicineText miningTreatment OutcomeHeart failureMedicineHumans030212 general & internal medicinebusinessIntensive care medicineDiureticsThe New England journal of medicine
researchProduct

Soluble ST2 and Diuretic Efficiency in Acute Heart Failure and Concomitant Renal Dysfunction

2021

Abstract Background Identifying patients at risk of poor diuretic response in acute heart failure (AHF) is critical to make prompt adjustments in therapy. The objective of this study was to investigate whether the circulating levels of soluble ST2 predict the cumulative diuretic efficiency (DE) at 24 and 72 hours in patients with AHF and concomitant renal dysfunction. Methods and Results This is a post hoc analysis of the IMPROVE-HF trial, in which we enrolled 160 patients with AHF and renal dysfunction (estimated glomerular filtrate rate of Conclusions In patients with AHF and renal dysfunction at presentation, circulating levels of sST2 were independently and negatively associated with a …

Heart Failuremedicine.medical_specialtybusiness.industrymedicine.medical_treatment030204 cardiovascular system & hematologymedicine.disease03 medical and health sciences0302 clinical medicineFurosemideNegatively associatedInternal medicineConcomitantHeart failureAcute DiseasePost-hoc analysisCardiologyHumansMedicineKidney DiseasesIn patient030212 general & internal medicineDiureticDiureticsCardiology and Cardiovascular MedicinebusinessJournal of Cardiac Failure
researchProduct

Old and New Drugs for Treatment of Advanced Heart Failure.

2020

Background: Advanced heart failure (HF) is a progressive disease with high mortality and limited medical therapeutic options. Long-term mechanical circulatory support and heart transplantation remain goldstandard treatments for these patients; however, access to these therapies is limited by the advanced age and multiple comorbidities of affected patients, as well as by the limited number of organs available. Methods: Traditional and new drugs available for the treatment of advanced HF have been researched. Results: To date, the cornerstone for the treatment of patients with advanced HF remains water restriction, intravenous loop diuretic therapy and inotropic support. However, many patien…

Inotropemedicine.medical_specialtymedicine.drug_classmedicine.medical_treatment030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineFurosemideDrug DiscoverymedicineHumansDecompensation030212 general & internal medicine: Dobutamine dopamine nitroglycerine sodium nitroprusside vaptans ivabradineIntensive care medicineDiureticsSimendanPharmacologyHeart transplantationHeart Failurebusiness.industryLevosimendanLoop diureticmedicine.diseasePrognosisOmecamtiv mecarbilIstaroximeHeart failurebusinessmedicine.drugCurrent pharmaceutical design
researchProduct

Intercurrent factors associated with the development of open-angle glaucoma in The European Glaucoma Prevention Study

2007

Purpose: To evaluate the intercurrent factors for the development of open-angle glaucoma (OAG) in ocular hypertensive patients who were enrolled in the European Glaucoma Prevention Study (EGPS). Design: Randomized, double masked, controlled clinical trial. Methods: setting: Multicenter. study population: A total of 1,077 patients fulfilled a series of inclusion criteria, including intraocular pressure (IOP) 22 to 29 mm Hg, normal and reliable visual fields (VFs) and normal optic disks. intervention: Treatment with dorzolamide or placebo. main outcome measures: Glaucoma-related VF or optic disk changes. Clinical data were collected every six months during a five-year follow-up. Proportional …

Intraocular pressuremedicine.medical_specialtyTime Factorsgenetic structuresOpen angle glaucomaSettore MED/06 - Oncologia MedicaOptic DiskOptic diskOcular hypertensionGlaucomaThiopheneslaw.inventionCorneaDouble-Blind MethodDorzolamideRandomized controlled trialRisk FactorslawOphthalmologyConfidence IntervalsPrevalencemedicineHumansDiureticsglaucoma ocular hypertension intercurrent risk factorsAntihypertensive AgentsIntraocular PressureProportional Hazards ModelsRetrospective StudiesSulfonamidesbusiness.industryHazard ratioRetinal Hemorrhagemedicine.diseaseeye diseasesEuropeOphthalmologyTreatment OutcomeCardiovascular Diseasessense organsbusinessGlaucoma Open-AngleFollow-Up Studiesmedicine.drug
researchProduct

Swelling of glial cells in lactacidosis and by glutamate: significance of Cl(-)-transport.

1993

Swelling of glial and nerve cells is characteristic of brain damage in cerebral ischemia or trauma. The therapeutical efficiency of inhibition of Cl(-)-transport by a novel antagonist, the diuretic torasemide, on cytotoxic swelling of glial cells from lactacidosis, or glutamate was analyzed. Lactacidosis and the interstitial accumulation of glutamate are hallmarks of the pathophysiological alterations in ischemic or traumatic brain tissue. C6 glioma cells harvested from culture and suspended in a physiological medium were either exposed to pH 6.2, or 5.0 by lactic acid, or exposed to 1 mM glutamate at normal pH. Cell swelling and viability were quantified by flow cytometry. Lactacidosis of …

IschemiaGlutamic AcidBrain EdemaPharmacologyIon Channelschemistry.chemical_compoundChloridesGlutamatesChloride ChannelsmedicineTumor Cells CulturedAnimalsDiureticsMolecular BiologyAcidosisCell SizeSulfonamidesIon TransportChemistryGeneral NeuroscienceGlutamate receptorMembrane ProteinsGlutamic acidmedicine.diseaseTorsemideLactic acidRatsmedicine.anatomical_structureBiochemistryCell cultureNeurogliaAcidosis LacticNeurology (clinical)Swellingmedicine.symptomNeurogliaDevelopmental BiologyBrain research
researchProduct